Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Stone

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Journal of Biophotonics|April 15, 2021
Sub millimetre flexible fibre probe for background and fluorescence free Raman spectroscopyStephanos Yerolatsitis, András Kufcsák, Katjana Ehrlich, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2021
The Effects of Acute Δ<sup>9</sup>-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy StudyMichael A P Bloomfield, Katherine Petrilli, Rachel Lees, et al.
Frontiers in Immunology|February 27, 2023
Specific <i>in situ</i> immuno-imaging of pulmonary-resident memory lymphocytes in human lungsDuncan C Humphries, Richard A O'Connor, Hazel L Stewart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
IEEE Transactions on Bio-Medical Engineering|April 6, 2023
Computational Fluorescence Suppression in Shifted Excitation Raman SpectroscopyNia C Jenkins, Katjana Ehrlich, Andras Kufcsak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinRobin L Carhart-Harris, David Erritzoe, Tim Williams, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal of Biophotonics|April 15, 2021
Sub millimetre flexible fibre probe for background and fluorescence free Raman spectroscopyStephanos Yerolatsitis, András Kufcsák, Katjana Ehrlich, et al.
The International Journal of Neuropsychopharmacology|October 12, 2017
Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal SymptomsGemma Modinos, Fatma Simsek, Jamie Horder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomesGemma Modinos, Anja Richter, Alice Egerton, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 8, 2021
The Effects of Acute Δ<sup>9</sup>-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy StudyMichael A P Bloomfield, Katherine Petrilli, Rachel Lees, et al.
Frontiers in Immunology|February 27, 2023
Specific <i>in situ</i> immuno-imaging of pulmonary-resident memory lymphocytes in human lungsDuncan C Humphries, Richard A O'Connor, Hazel L Stewart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 15, 2018
Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 4, 2018
Correction: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosisGemma Modinos, Fatma Şimşek, Matilda Azis, et al.
Psychopharmacology|August 15, 2025
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trialPeter C T Hawkins, Adam J Schwarz, James M Stone, et al.
IEEE Transactions on Bio-Medical Engineering|April 6, 2023
Computational Fluorescence Suppression in Shifted Excitation Raman SpectroscopyNia C Jenkins, Katjana Ehrlich, Andras Kufcsak, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybinRobin L Carhart-Harris, David Erritzoe, Tim Williams, et al.
Pageof 13